Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
50
DRUG Quote, Financials, Valuation and Earnings
Last price:
$82.24
Seasonality move
:
-32.54%
Day range:
$81.55 - $88.67
52-week range:
$23.18 - $97.75
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
10.85x
Volume:
188K
Avg. volume:
166.2K
1-year change:
104.38%
Market cap:
$639.5M
Revenue:
--
EPS (TTM):
-$1.24
Earnings Data
Next earnings date for DRUG
Feb 12
2026
Most recent earnings per share
-$0.41
Beat by $0.31
(Dec 24/2025)
Consensus Estimate
-$0.72
(Dec 24/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
DRUG Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/12/2026 | Q4 | -- | -- | -- | -$0.82 | -- |
| 12/24/2025 | Q3 | -- | -- | -$0.41 | -$0.72 | $0.31 |
| 08/14/2025 | Q2 | -- | -- | -$0.53 | -$0.65 | $0.11 |
| 05/15/2025 | Q1 | -- | -- | -$0.29 | -$0.33 | $0.04 |
| 02/13/2025 | Q4 | -- | -- | $0.01 | -$0.35 | $0.35 |
| 09/30/2024 | Q3 | -- | -- | -$0.13 | -$0.43 | $0.30 |
| 06/30/2024 | Q2 | -- | -- | $0.04 | -- | -- |
| 03/31/2024 | Q1 | -- | -- | -$0.10 | -- | -- |
| 12/31/2023 | Q4 | -- | -- | -$0.32 | -- | -- |
| 09/30/2023 | Q3 | -- | -- | -$0.30 | -- | -- |
| 06/30/2023 | Q2 | -- | -- | -$0.29 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$0.40 | -- | -- |
| 02/14/2023 | Q4 | -- | -- | -$0.48 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$0.76 | -- | -- |
| 08/30/2022 | Q2 | -- | -- | -$0.88 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$1.50 | -- | -- |
| 02/14/2022 | Q4 | -- | -- | -$1.63 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -$0.96 | -- | -- |
| 08/30/2021 | Q2 | -- | -- | -$1.22 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.64 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.45 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.24 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.02 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.00 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$0.02 | -- | -- |
Bright Minds Biosciences, Inc. Earnings Questions
-
How Much did Bright Minds Biosciences, Inc. Generate in Revenue Last Quarter?
Bright Minds Biosciences, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Bright Minds Biosciences, Inc. Beat Earnings Last Quarter?
Bright Minds Biosciences, Inc. announced earnings per share of -$0.41 which represents a beat of analyst forecast a -$0.72 per share.
-
Is Bright Minds Biosciences, Inc. Profitable?
Bright Minds Biosciences, Inc. reported -$12.3K that represents -$0.00 per share over the last quarter.
-
What is the Analyst Consensus for Bright Minds Biosciences, Inc. EPS Next Year?
Bright Minds Biosciences, Inc.'s earnings are forecast to decrease from -$1.27 per share to -$1.67 per share next year representing a decrease of -462.72%.
-
When is Bright Minds Biosciences, Inc.'s Earnings Date?
Bright Minds Biosciences, Inc.'s next earnings date is February 12, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 27
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Sell
20
SMX alert for Dec 27
SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.
Sell
11
CDNAF alert for Dec 27
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
